In this study, we confirmed that the less aggressive breast cancer cell line, namely MCF-7, demonstrated a slight EGFR expression, and 7-fold IGF-IR and 2.5-fold HER2 increased levels, respectively, as compared to MDA-MB-231 cells (Figure 2C). This evidence concerns the gene EGFR and breast carcinoma.